OFFER DEADLINE06/02/2019 00:00 - Europe/Brussels
EU RESEARCH FRAMEWORK PROGRAMMENot funded by an EU programme
ORGANISATION/COMPANYIMIBIC (Maimonides Biomedical Research Institute)
IMIBIC HOSTING OFFER:
La Caixa INPhINIT INCOMING Doctoral Fellowship Programme
IMIBIC, located in Cordoba, southern Spain, is a partnership between the University of Cordoba (UCO) and the Reina Sofia University Hospital. IMIBIC offers a multidisciplinary environment focused on results-oriented research and based on precision medicine and excellence in science. IMIBIC is accredited with the Excellence distinction from the National Institute of Health Carlos III and the “HR Excellence in Research” by the EC.
The Institute is structured in 44 research groups that cooperate in the implementation of five scientific programmes. IMIBIC offers an active environment in which to conduct high-level scientific research. Regular seminars and research events offer the opportunity to meet with national and international experts covering a diverse range of topics in biomedicine. Advanced training of our PhD students is provided primarily through the Doctoral Program in Biomedicine (UCO), hosted at the IMIBIC and integrated by leading scientists from the University and the Hospital. Results from research activities are exposed yearly in the IMIBIC Young Investigator Meetings, providing an ideal environment to strengthen the skills and knowledge of young scientists and to foster translational research by bringing together experimental basic and medical sciences.
IMIBIC is young and fast growing research center. It operates in a brand new building located within the UCO Health Sciences Campus and next to the University Hospital. It hosts over 600 researchers, and offers the latest technology, equipment and laboratories to support the technical needs of the research community.
Cordoba is a medium sized city located in the hearth of Andalusia, with excellent transport connections to the main cities of Spain and both to the Mediterranean and Atlantic coasts. Rich in history and culture, Cordoba is a friendly and welcoming city, with high standard of living, making it an ideal location for international students wishing to carry out their doctoral studies in Spain.
Dr.Antonio Rivero Román (email@example.com)
RESEARCH PROJECT/RESEARCH GROUP
IMIBIC group GC26: https://www.imibic.org/grupo/45
The Clinical virology and zoonosis Research Group of the IMIBIC is under the leadership of Antonio Rivero Román. Our research group studies infection diseases using two main approaches:
1 Clinical and epidemiological studies (including clinical trials). Our objective in these studies is to identify and differentiate risk factors, clinical features and the efficacy/safety of new treatments in order to improve the prognosis of infectious diseases.
2 Pathogenesis studies for use in developing specific clinical strategies. The most relevant are our studies on immunopathology.
All our studies start by identifying a clinical problem, which we try to solve using an experimental approach. Hence, our aim is for our scientific findings to have an impact on healthcare solutions and to improve disease prognosis (translational research).
Specific lines of research are as follows:
1) HIV INFECTION: Our lines of research concerning the natural history of HIV infection include
- Fatty liver disease in HIV-infected patients
- Resistance to HIV infection
- Innate immunity against HIV
- The evaluation of new therapeutic regimens for the treatment of HIV infection
2) HEPATITIS C VIRUS INFECTION: The research in this section encompass 5 main lines:
- Epidemiology of HCV infection
- The natural history of fibrosis/cirrhosis of the liver in HCV-infected patients
- Evaluation of new therapeutic regimens for the treatment of HCV infection
- Optimization of HCV treatment
- Prediction of response to HCV treatment
3) EMERGING ZOONOSIS: This research section is focusing in Hepatitis E virus:
- Epidemiology and routes of transmission of HEV infection
- Identification of animal reservoir of HEV
- Clinical implications and complications of HEV infection
- Development of new HEV diagnosis approaches
- Strategies to HEV inactivation and prevention
- Promotion of “ONE-HEALTH”
-Job position description:
This is an exciting opportunity for a talented predoctoral investigator to join a multidisciplinary research team working on infectious diseases investigating clinical virology and emerging zoonosis. This research has the potential to inform new strategies for risk detection, prevention and treatment of HIV, HCV and emerging zoonosis. The applicant will develop a mentored research in one of the priority research lines of the group. During the PhD period, the researcher will acquire knowledge on the infectious diseases field, developing lab and scientific skills needed to face an early scientific career. Specifically, the applicant will be instructed in skills and basics of molecular biology (PCR, qPCR, ddPCR, and sequencing), DNA/ARN extraction from different tissues, development of ELISA, in vivo and in vitro models, among others. Furthermore, the researcher will be formed in the design of epidemiological and clinical studies, acquiring the bioinformatics skills needed for its analysis and critical review.
We offer an inspiring research environment, including state-of-the-art research facilities, enthusiastic scientists of different disciplines (medical doctors, veterinary science, clinical pharmacologist, and biologist), and an exciting interdisciplinary project of considerable fundamental and applied relevance to population. We are committed to excellent science and to fostering the careers of promising young scientists.
1) At the call deadline (6th Feb 2019), applicants must be in the first four years (full-time equivalent research experience) of their research careers and not yet have been awarded a doctoral degree.
2) At the time of recruitment, candidates must comply with one of the following options:
- To have completed the studies that lead to an official university degree adapted to the European Higher Education Area awarding 300 ECTS credits, of which at least 60 ECTS credits must correspond to master level.
- To have completed a degree in university not adapted to the European Higher Education Area that gives access to doctoral studies. The verification of an equivalent level of studies to the ones mentioned above will be made by the university when the admission procedure starts.
3) Candidates must not have resided or have carried out their main activity (work, studies, etc.) in Spain for more than 12 months in the 3 years immediately prior to the call deadline (6th Feb 2019). Short stays, such as holidays, done in a country other than their country of usual residence (where they carried out their main activity), will be considered as time spent in their country of usual residence.
4) Candidates must have a demonstrable level of English (B2 or higher).
5) Only candidates whose applications meet all the requirements of the call may be accepted.
You can find this offer via the Offer Finder, available at: https://hosts.lacaixafellowships.org/finder
Select “IMIBIC – Maimonides Biomedical Research Institute to Cordoba” from the dropdown list under “RESEARCH CENTER”
You can also search the position by its title "CLINICAL VIROLOGY AND ZOONOSIS" under "SEARCH BY PROJECT TITLE / JOB POSITION TITLE".
How to Apply:
If you want to apply for an INPhINIT fellowship, click on the link below to create your personal account and fill in the on-line application form: https://www.lacaixafellowships.org/index.aspx
6 February 2019: Application deadline.
20 February 2019: Deadline for submitting the language certificate.
23 April 2019: Notification of the shortlist results.
28 and 29 May 2019: Face-to-face interviews in Barcelona.
4 June 2019: Publication of the final list of selected candidates.
4 June 2019 to 5 July 2019: Matching between the research centres – fellows.
Call for applications:
The responsibility for the hosting offers published on this website, including the hosting description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.